Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20152306 | 0.89 | LMNA (0.36) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL12109062 | 0.87 | LMNA (0.30) | LMNA | |
| SCHEMBL20152307 | 0.87 | MEN1 (0.35) | PDK2MEN1LMNAMAPTKMT2A | |
| SCHEMBL20152335 | 0.86 | — | — | |
| SCHEMBL20152312 | 0.81 | MCL1 (0.35) | — | |
| SCHEMBL20152317 | 0.79 | PDK2 (0.38) | PDK2MEN1LMNAMAPTKMT2A | |
| SCHEMBL25495732 | 0.77 | PDK2 (0.39) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL12109064 | 0.77 | ALDH1A1 (0.35) | LMNA | |
| SCHEMBL13371830 | 0.76 | PDK2 (0.35) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL19035959 | 0.76 | LMNA (0.36) | KDM4EMEN1LMNAMAPTOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844059-B2 | Heterocyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-11-24 | — | — | US | disclosed |
| US-20180134706-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
| US-20180134706-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134706-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | OR10J3, HDAC10, RBM12 | PDK2 1425/4885KDM4E 565/4885MEN1 2863/4885 |
| US-10844059-B2 | Heterocyclic compound and organic electroluminescence device including the same | OR10J3, HDAC10, RBM12 | PDK2 1425/4885KDM4E 565/4885MEN1 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.